Taken together, these findings highlight the critical regulatory axis of FTH1 and PYCR1 in pancreatic cancer cell metabolism and survival, suggesting a shared pathway that influences malignancy and potential treatment targets in PDAC. This evidence concerns the gene FTH1 and familial pancreatic carcinoma.